Effect of myocardial infarction-associated transcripts on retinoblastoma
-
摘要:
目的 探讨心肌梗死相关转录本(MIAT)靶向miR-145对视网膜母细胞瘤增殖和凋亡的影响。 方法 选取2015年9月—2020年9月在郑州大学附属儿童医院因视网膜母细胞瘤行眼球摘除患儿30例,收集患儿肿瘤组织及癌旁组织。培养人视网膜母细胞瘤细胞Y79,按照随机数字表法分为si-NC组、si-MIAT组、miR-NC组、miR-145组、si-MIAT+anti-miR-NC组、si-MIAT+anti-miR-145组。采用RT-qPCR检测细胞MIAT和miR-145的表达;CCK-8检测细胞增殖;流式细胞术检测细胞凋亡;Western blotting检测CyclinD1、p21、Bcl-2、Bax、p-PI3K、p-Akt蛋白表达;双荧光素酶报告检测MIAT与miR-145的靶向关系。 结果 与癌旁组织比较,视网膜母细胞瘤组织中MIAT表达显著上调(3.61±0.28 vs. 1.05±0.11),miR-145表达显著下调(0.33±0.03 vs. 1.03±0.09,均P<0.05)。与si-NC组比较,si-MIAT组细胞活力显著下调;细胞凋亡率显著上调;p-PI3K蛋白、p-Akt蛋白表达显著下调(均P<0.05)。与miR-NC组比较,miR-145组细胞活力显著下调;细胞凋亡率显著上调(均P<0.05)。与si-MIAT+anti-miR-NC组比较,si-MIAT+anti-miR-145组细胞活力显著上调;细胞凋亡率显著下调;p-PI3K蛋白、p-Akt蛋白表达显著上调(均P<0.05)。 结论 抑制MIAT表达、上调miR-145表达可促进视网膜母细胞瘤凋亡,抑制增殖,其机制与PI3K/Akt通路有关。 -
关键词:
- 长链非编码RNAMIAT /
- 微小RNA-145 /
- 磷脂酰肌醇-3激酶/蛋白激酶B信号通路 /
- 视网膜母细胞瘤细胞 /
- 增殖 /
- 凋亡
Abstract:Objective To explores the effect of lncRNA MIAT targeting miR-145 on the proliferation and apoptosis of retinoblastoma. Methods From September 2015 to September 2020, 30 children with retinoblastoma underwent enucleation in Children ' s Hospital of Zhengzhou University were selected, and tumor tissues and adjacent tissues were collected. Human retinoblastoma cells (Y79) were cultured and divided into si-NC, si-MIAT, miR-NC, miR-145, si-MIAT + anti-miR-NC and si-MIAT + anti-miR-145 groups according to the random number table method. RT-qPCR was used in detecting the expression levels of MIAT and miR-145 in the cells. CCK-8 was used in detecting cell proliferation, and flow cytometry was used in detecting cell apoptosis. Cyclin D1, p21, Bcl-2, Bax, p-PI3K and p-Akt protein expression levels were detected with Western blotting, and dual luciferase reporter was used in detecting the targeted relationship between MIAT and miR-145. Results Compared with adjacent tissues, the expression of MIAT in retinoblastoma tissue was significantly up-regulated, and the expression of miR-145 was significantly down-regulated (3.61±0.28 vs. 1.05±0.11, 0.33±0.03 vs. 1.03±0.09, all P < 0.05). Compared with the si-NC group, cell viability in the si-MIAT group was significantly down-regulated, mortality rate was significantly up-regulated, and p-PI3K protein and p-Akt protein expression were significantly down-regulated (all P < 0.05). Compared with the miR-NC group, cell viability in the miR-145 group showed significantly down-regulated, apoptosis rate was significantly up-regulated (all P < 0.05). Compared with the si-MIAT + anti-miR-NC group, cell viability was significantly up-regulated in the si-MIAT + anti-miR-145 group, cell apoptosis rate was significantly down-regulated, whereas the expression levels of p-PI3K and p-Akt proteins were significantly up-regulated (all P < 0.05). Conclusion The inhibition of MIAT expression and up-regulation of miR-145 expression can promote apoptosis and inhibit the proliferation of retinoblastoma. The mechanism is related to the PI3K/Akt pathway. -
表 1 视网膜母细胞瘤组织与正常视网膜组织MIAT和miR-145表达量比较(x±s,ni=30)
Table 1. Comparison of MIAT and Mir-145 expression in retinoblastoma tissues and normal retinal tissues(x±s, ni=30)
组织来源 MIAT miR-145 癌旁组织 1.05±0.11 1.03±0.09 视网膜母细胞瘤组织 3.61±0.28 0.33±0.03 t值 46.610 40.415 P值 < 0.001 < 0.001 表 2 干扰MIAT表达对视网膜母细胞瘤细胞增殖和凋亡的影响(x±s,ni=9)
Table 2. Effect of interfering MIAT expression on proliferation and apoptosis of retinoblastoma cells (x±s, ni=9)
组别 MIAT 增殖(OD490) CyclinD1蛋白 p21蛋白 凋亡率(%) Bcl-2蛋白 Bax蛋白 24 h 48 h 72 h si-NC 1.00±0.10 0.66±0.06 0.76±0.07 0.85±0.08 0.85±0.08 0.22±0.02 8.64±0.55 0.89±0.09 0.29±0.02 si-MIAT 0.35±0.03 0.21±0.02 0.32±0.03 0.44±0.04 0.30±0.03 0.86±0.08 42.35±3.68 0.34±0.04 0.87±0.08 t值 18.678 21.345 17.332 13.752 19.312 23.283 27.179 16.753 21.101 P值 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 表 3 miR-145过表达对视网膜母细胞瘤细胞增殖和凋亡的影响(x ±s,ni=9)
Table 3. Effect of overexpression of miR-145 on proliferation and apoptosis of retinoblastoma cells (x ±s, ni=9)
组别 miR-145 增殖(OD490) CyclinD1蛋白 p21蛋白 凋亡率(%) Bcl-2蛋白 Bax蛋白 24 h 48 h 72 h miR-NC 1.03±0.08 0.64±0.06 0.79±0.08 0.88±0.08 0.86±0.08 0.32±0.03 9.62±0.57 0.91±0.09 0.28±0.02 miR-145 3.49±0.31 0.20±0.02 0.36±0.04 0.45±0.05 0.30±0.03 0.90±0.09 45.38±4.36 0.37±0.03 0.89±0.09 t值 23.051 20.871 14.423 12.856 19.663 18.341 24.398 17.076 19.849 P值 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 表 4 双荧光素酶报告实验(x±s,ni=9)
Table 4. Double luciferase reporter assay(x±s, ni=9)
组别 WT-MIAT MUT-MIAT miR-NC 1.01±0.09 1.00±0.09 miR-145 0.36±0.04 1.01±0.10 t值 19.799 < 0.001 P值 < 0.001 0.999 表 5 抑制miR-145表达逆转了干扰MIAT对视网膜母细胞瘤细胞增殖和凋亡的影响(x±s,ni=9)
Table 5. The expressions of proliferation and apoptosis related proteins detected by Western blotting(x±s, ni=9)
组别 增殖(OD490) CyclinD1蛋白 p21蛋白 凋亡率(%) Bcl-2蛋白 Bax蛋白 24 h 48 h 72 h si-MIAT+anti-miR-NC 0.29±0.02 0.41±0.04 0.55±0.05 0.25±0.02 0.84±0.08 48.09±5.29 0.26±0.02 0.92±0.09 si-MIAT+anti-miR-145 0.58±0.05 0.72±0.07 0.89±0.09 0.88±0.08 0.24±0.02 9.68±0.92 0.83±0.08 0.36±0.04 t值 16.155 11.535 9.907 22.920 21.828 21.460 20.737 17.058 P值 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 表 6 PI3K/Akt信号通路相关蛋白表达(x±s,ni=9)
Table 6. Expression of PI3K/Akt signaling pathway related proteins (x±s, ni=9)
组别 p-PI3K蛋白 p-Akt蛋白 si-NC 0.90±0.10 0.89±0.09 si-MIAT 0.32±0.03a 0.30±0.03a si-MIAT+anti-miR-NC 0.31±0.03 0.29±0.03 si-MIAT+anti-miR-145 0.88±0.08b 0.91±0.09b F值 218.159 244.183 P值 < 0.001 < 0.001 注:与si-NC组比较,aP<0.05;与si-MIAT+anti-miR-NC组比较,bP<0.05。 -
[1] SINGH L, KASHYAP S. Update on pathology of retinoblastoma[J]. Int J Ophthalmol, 2018, 11(12): 2011-2016. [2] CHÁVEZ-LÓPEZ M G, ZÙÑGA-GARCÍA V, CASTRO-MAGDONEL B E, et al. Eag1 gene and protein expression in human retinoblastoma tumors and its regulation by pRb in hela cells[J]. Genes (Basel), 2020, 11(2): 119-129. doi: 10.3390/genes11020119 [3] 黄晓寒, 唐少华, 刘爽, 等. 过表达SOX11基因对人视网膜母细胞瘤Y79细胞增殖凋亡影响的研究[J]. 河北医学, 2018, 24(9): 1409-1412. doi: 10.3969/j.issn.1006-6233.2018.09.001HUAGN X H, TANG S H, LIU S, et al. Effects of SOX11 overexpression on proliferation and apoptosis of retinoblastoma of Y79 cells[J]. Hebei Medicine, 2018, 24(9): 1409-1412. doi: 10.3969/j.issn.1006-6233.2018.09.001 [4] HUANG X L, GAO Y, QIN J J, et al. lncRNA-MIAT promoted proliferation and invasion of HCC cells via sponging miR-214[J]. Am J Physiol Gastrointest Liver Physiol, 2017, 314(5): 559-565. [5] ZHANG C Y, XIE L S, LIANG H L, et al. LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis[J]. IUBMB Life, 2019, 71(7): 845-853. doi: 10.1002/iub.2001 [6] ZHANG C Y, XIE L S, FU Y, et al. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR01/INCENP axis and interacting with SOX2[J]. J Cell Physiol, 2020, 235(11): 7933-7944. doi: 10.1002/jcp.29448 [7] DONG G, ZHANG S S, SHEN S, et al. SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle[J]. Cell Death Dis, 2020, 11(10): 837. doi: 10.1038/s41419-020-03039-y [8] WANG Y C, ZHOU S L, ZHAO W J, et al. Association between functional polymorphisms in the flanking region of miR-143/145 and risk of papillary thyroid carcinoma: A case-control study[J]. Medicine, 2020, 99(49): e23560. DOI: 10.1097/MD.0000000000023560. [9] 颜子千, 盛智梅, 邓梓坤, 等. miR-145通过靶向吞噬和细胞活力蛋白1抑制乳腺癌细胞侵袭[J]. 中国生物化学与分子生物学报, 2019, 35(12): 1392-1399. https://www.cnki.com.cn/Article/CJFDTOTAL-SWHZ201912012.htmYAN Z Q, SHENG Z M, DENG Z K, et al. MiR-145 inhibits invasion of breast cancer cells by targeting ELMO1[J]. Chinese Journal of Biochemistry and Molecular Biology, 2019, 35(12): 1392-1399. https://www.cnki.com.cn/Article/CJFDTOTAL-SWHZ201912012.htm [10] 姜华, 夏杰军, 赵军阳, 等. 视网膜母细胞瘤房水及肿瘤组织的基因组信息分析初探[J]. 中华介入放射学电子杂志, 2020, 8(1): 57-61. doi: 10.3877/cma.j.issn.2095-5782.2020.01.012JIANG Hua, XIA Jie-jun, ZHAO Jun-yang, et al. Genomic analysis of aqueous humor and tumor tissue in retinoblastoma[J]. Chinese Journal of Interventional Radiology (Electronic Edition), 2020, 8(1): 57-61. doi: 10.3877/cma.j.issn.2095-5782.2020.01.012 [11] 林壮玲, 张平. 视网膜母细胞瘤诊疗的研究进展[J]. 眼科学报, 2020, 35(4): 271-278. https://www.cnki.com.cn/Article/CJFDTOTAL-YKXB202004009.htmLIN Z L, ZHANG P. Research progress on the diagnosis and treatment of retinoblastoma[J]. Eye Science, 2020, 35(4): 271-278. https://www.cnki.com.cn/Article/CJFDTOTAL-YKXB202004009.htm [12] 金梅, 尹鹏程, 徐荣, 等. 敲低长链非编码RNA MIAT对视网膜母细胞瘤肿瘤成球, 侵袭及裸鼠移植瘤生长的影响[J]. 局解手术学杂志, 2020, 29(7): 523-528. https://www.cnki.com.cn/Article/CJFDTOTAL-JJXZ202007003.htmJIN M, YIN P C, XU R, et al. Effects of long non-coding RNA MIAT knockdown on spheroidization, invasion and growth of SO-RB50 cells in nude mice[J]. Journal of Regional Anatomy and Operative Surgery, 2020, 29(7): 523-528. https://www.cnki.com.cn/Article/CJFDTOTAL-JJXZ202007003.htm [13] ZONG Z H, DU Y P, GUAN X, et al. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182[J]. J Exp Clin Cancer Res, 2019, 38(1): 437. doi: 10.1186/s13046-019-1437-z [14] 周栩平, 魏琛. SNHG1靶向调控miR-145对神经母细胞瘤细胞增殖, 侵袭和迁移能力的影响[J]. 郑州大学学报(医学版), 2020, 55(1): 69-73. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK202001017.htmZHOU X P, WEI C. Effects of lncRNA SNHG1 targeting miR-145 on proliferation, invasion and migration of neuroblastoma cells[J]. Journal of Zhengzhou University(Medical Sciences), 2020, 55(1): 69-73. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK202001017.htm [15] 闫义涛, 王晓丽, 谷圆圆, 等. 长链非编码RNA MALAT1靶向miR-570-3p对人视网膜母细胞瘤细胞系SO-Rb50增殖、凋亡和侵袭的调控作用[J]. 中国免疫学杂志, 2018, 34(11): 1621-1625, 1631. doi: 10.3969/j.issn.1000-484X.2018.11.005YAN Y T, WANG X L, GU Y Y, et al. Long noncoding RNA MALAT1 regulates cell proliferation, apoptosis and invasion of human retinoblastoma cell SO-Rb50 via targeting miR-570-3p[J]. Chinese Journal of Immunology, 2018, 34(11): 1621-1625, 1631. doi: 10.3969/j.issn.1000-484X.2018.11.005 [16] 杨颖, 张瑞丽, 杨志芳, 等. GP73调控PI3K/Akt通路介导肝癌细胞索拉非尼耐药机制的实验研究[J]. 中华全科医学, 2019, 17(1): 6-9, 90. doi: 10.16766/j.cnki.issn.1674-4152.000585YANG Y, ZHANG R L, YAGN Z F, et al. An experimental study on roles of GP73 and PI3K/Akt pathway in the Sorafenib resistant mechanism in patients with hepatocellular carcinoma[J]. Chinese Journal of General Practice, 2019, 17(1): 6-9, 90. doi: 10.16766/j.cnki.issn.1674-4152.000585 [17] YAO J, XU M, LIU Z Y. Rapamycin inhibits proliferation and apoptosis of retinoblastoma cells through PI3K/AKT signaling pathway[J]. Oncol Lett, 2020, 19(4): 2950-2956. [18] 张铮. 苦参碱对视网膜母细胞瘤细胞增殖与凋亡及PI3K/Akt信号通路的影响[J]. 四川中医, 2019, 37(4): 57-60. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201904021.htmZHANG Z. Effects of matrine on proliferation, apoptosis and PI3K/Akt signaling pathway for retinoblastoma cells[J]. Journal of Sichuan of Traditional Chinese Medicine, 2019, 37(4): 57-60. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201904021.htm